Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

RIN3 Inhibitors

The inhibition of RIN3, a protein implicated in endocytic processes and actin cytoskeleton rearrangement, can be achieved through the disruption of various signaling pathways where it plays a role. For instance, the inhibition of Src family kinases, which are upstream regulators of several endocytic components, results in the impairment of the signaling cascade necessary for RIN3's action in endocytosis. Furthermore, the direct inhibition of clathrin and dynamin, which are critical for vesicle formation and scission during endocytosis, would impede the RIN3-dependent endocytic pathways by obstructing the recruitment and function of RIN3 at the vesicle formation sites. Similarly, targeting the actin polymerization process, by inhibiting N-WASP and formins, can significantly alter the actin-dependent endocytic mechanisms in which RIN3 is involved, thereby reducing its functional activity.

Additionally, the interference with small GTPases, such as Cdc42 and Rac1, and their respective GEF interactions, profoundly impacts the actin cytoskeleton organization. This disruption can negatively influence RIN3's involvement in cytoskeletal-dependent endocytic processes. Inhibiting cytohesins, which modulate Arf GTPase activity, can also indirectly affect RIN3's role in endocytic trafficking by altering the Arf-dependent regulation of vesicle formation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Saracatinib

379231-04-6sc-364607
sc-364607A
10 mg
200 mg
$113.00
$1035.00
7
(1)

Src kinase inhibitor that disrupts Src family kinase-mediated signaling, which RIN3 relies on for its role in endocytic processes.

Pitstop 2

1419320-73-2sc-507418
10 mg
$360.00
(0)

Clathrin inhibitor that impairs clathrin-mediated endocytosis, a process in which RIN3 is implicated through its interaction with Rab5.

Wiskostatin

253449-04-6sc-204399
sc-204399A
sc-204399B
sc-204399C
1 mg
5 mg
25 mg
50 mg
$48.00
$122.00
$432.00
$812.00
4
(1)

N-WASP inhibitor that affects actin polymerization, a key step in endocytic vesicle formation, where RIN3 is known to participate.

SecinH3

853625-60-2sc-203260
5 mg
$273.00
6
(1)

Inhibitor of cytohesins, affecting Arf GTPase activity, which indirectly disrupts RIN3-associated endocytic trafficking.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

Cdc42 inhibitor that impacts actin cytoskeleton organization, indirectly influencing RIN3's role in actin-dependent endocytic pathways.

ZCL278

587841-73-4sc-507369
10 mg
$115.00
(0)

Inhibitor of Cdc42-GEF interaction, affecting actin dynamics and membrane trafficking processes involving RIN3.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Dynamin inhibitor that blocks clathrin-dependent and independent endocytosis, both of which RIN3 is associated with.

Dynamin Inhibitor II

1119-97-7sc-203931
sc-203931A
sc-203931B
sc-203931C
5 g
250 g
500 g
1 kg
$46.00
$82.00
$122.00
$194.00
(1)

Dynamin GTPase activity inhibitor, which disrupts vesicle scission, a step in endocytosis where RIN3 may play a role.

EHT 1864

754240-09-0sc-361175
sc-361175A
10 mg
50 mg
$209.00
$872.00
12
(2)

Rac1 inhibitor that alters actin cytoskeleton rearrangement and cell migration processes, indirectly affecting RIN3 functions.

SMIFH2

340316-62-3sc-507273
5 mg
$140.00
(0)

Formin inhibitor that disrupts actin polymerization and thus potentially impacts RIN3-mediated endocytic mechanisms.